Hydrotherapy in Duchenne Muscular Dystrophy (DMD)
NCT06445985 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31
Last updated 2025-01-30
Summary
The goal of this clinical trial aims to establish if there are meaningful benefits to providing a hydrotherapy service for young people with Duchenne muscular dystrophy (DMD). The main aims are to: 1. to allocate a clinical physiotherapist to a project implementing hydrotherapy in young patients with DMD to establish whether there are meaningful benefits to their daily life. 2. to conduct patient and parent interviews to understand the barriers to completing a hydrotherapy intervention and ensure future research addresses meaningful outcomes for those with DMD.
Conditions
Interventions
- OTHER
-
Hydrotherapy
Physiotherapy led pool session
Sponsors & Collaborators
-
Duchenne UK
collaborator UNKNOWN -
Lancashire Teaching Hospitals NHS Foundation Trust
lead OTHER
Principal Investigators
-
Christian De Goede · Lancashire Teaching Hospitals NHS Foundation Trust
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Years
- Max Age
- 25 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-02
- Primary Completion
- 2025-04-01
- Completion
- 2025-12-12
Countries
- United Kingdom
Study Locations
More Related Trials
-
Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients
NCT02196467 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Trial of Chronotherapy of Corticosteroids in Duchenne Muscular Dystrophy
NCT02036463 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2
NCT02484560 ·Status: UNKNOWN ·Phase: PHASE1
-
The U.K. NorthStar Clinical Network
NCT06711692 ·Status: NOT_YET_RECRUITING
-
Strength Training in Duchenne Muscular Dystrophy
NCT02421523 ·Status: COMPLETED ·Phase: NA
-
Nutritional Status and Therapy in DMD Patients
NCT06682585 ·Status: COMPLETED ·Phase: NA
-
Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD
NCT02972580 ·Status: ACTIVE_NOT_RECRUITING
-
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
NCT01462292 ·Status: COMPLETED ·Phase: PHASE2
-
Outcome Measures in Duchenne Muscular Dystrophy: A Natural History Study
NCT02780492 ·Status: COMPLETED
-
Twice Weekly Steroids and Exercise as Therapy for DMD
NCT04322357 ·Status: COMPLETED ·Phase: PHASE2
-
Natural History of Duchenne Muscular Dystrophy
NCT03882827 ·Status: RECRUITING
-
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
NCT02354352 ·Status: COMPLETED ·Phase: PHASE3
-
Research of Biomarkers in Duchenne Muscular Dystrophy Patients
NCT01380964 ·Status: COMPLETED
-
Characterization of New Phenotypes of Patients With Spinal Muscular Atrophy Treated With SMN Restoring Therapy
NCT06321965 ·Status: RECRUITING ·Phase: NA
-
Test-Retest Reliability of Pulmonary Function Tests in Patients With Duchenne's Muscular Dystrophy
NCT00207857 ·Status: WITHDRAWN
-
Effects of Low-level Mechanical Vibration on Bone Density in Ambulant Children Affected by Duchenne Muscular Dystrophy
NCT05281120 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy
NCT00873782 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT02579239 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy
NCT03067831 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD)
NCT02858362 ·Status: TERMINATED ·Phase: PHASE2
-
A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD Subjects
NCT01128855 ·Status: COMPLETED ·Phase: PHASE1
-
Breathlessness Assessment in Adult Patients With Myotonic Dystrophy Type 1
NCT04835298 ·Status: COMPLETED
-
Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD
NCT02834650 ·Status: COMPLETED ·Phase: NA
-
Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy
NCT01480245 ·Status: TERMINATED ·Phase: PHASE3
-
Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)
NCT03167255 ·Status: COMPLETED ·Phase: PHASE2